Mesenchymal stem cells as vehicles for targeted delivery of anti-angiogenic protein to solid tumors

Journal of Gene Medicine

Volumn 13, Issue 3, 2011, Pages 171-180

  Ghaedi, Mahboobe ^a,b,c   Soleimani, Masoud ^b   Taghvaie, Narges Mohammad ^b   Sheikhfatollahi, Mahmood ^d   Azadmanesh, Keyhan ^e   Lotfi, Abbas S ^b,c   Wu, Jian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

1 antitrypsin; Angiogenesis; Cancer gene therapy; Mesenchymal stem cells; Umbilical cord vein endothelial cells

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANGIOGENESIS INHIBITOR;

APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN SECRETION; SOLID TUMOR; UMBILICAL VEIN ENDOTHELIAL CELL; VIRAL GENE DELIVERY SYSTEM;

ALPHA 1-ANTITRYPSIN; ANGIOGENESIS INHIBITORS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; MESENCHYMAL STEM CELLS; PANCREATIC ELASTASE; PHENOTYPE; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; TRANSGENES; TRYPSIN INHIBITORS; UMBILICAL VEINS;

LENTIVIRUS;

EID: 79955162488     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1552     Document Type: Article

References (28)

1. Kang SG, Jeun SS, Lim JY, et al. Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells. Childs Nerv Syst 2008; 24: 293-302.
2. Molin D, Post MJ. Therapeutic angiogenesis in the heart: protect and serve. Curr Opin Pharmacol 2007; 7: 158-163.
3. Nyberg P, Ylipalosaari M, Sorsa T, et al. Trypsins and their role in carcinoma growth. Exp Cell Res 2006; 312: 1219-1228.
4. Zelvyte I, Stevens T, Westin U. α1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro. Cancer Cell Int 2004; 4: 7.
5. Abboud RT, Ford GT, Chapman KR. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med 2005; 4: 1-8.
6. Tamer M, Chisti Y. Production and recovery of recombinant protease inhibitor α1-antitrypsin. Enz Microb Tech 2001; 29: 611-620.
7. Huang H, Campbell SC, Nelius T, et al. Alpha1-antitrypsin inhibits angiogenesis and tumor growth. Int J Cancer 2004; 112: 1042-1048.
8. Streck CJ, Zhang Y, Zhou J, et al. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg 2005; 40: 236-243.
9. Diao Y, Ma J, Xiao WD, et al. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol 2007; 13: 4615-4619.
10. Komarova S, Kawakami Y, Stoff-Khalili MA, et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006; 5: 755-766.
11. Nakamizo A, Marini F, Amano T, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307-3318.
12. Nakamura K, Ito Y, Kawano Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155-1164.
13. Studeny M, Marini FC, Dembinski JL, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 1593-1603.
14. Ramírez-Zacarías JL, Castro-Muñozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992; 97: 493-497.
15. Covas DT, Siufi JL, Silva AR, et al. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 2003; 36: 1179-1183.
16. Salmon P, Trono D. Production and titration of lentiviral vectors. Curr Protoc Neurosci 2006; 4: 4.21.
17. Wege H, Le HT, Chui MS, et al. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 2003; 124: 432-444.
18. Yamamoto N, Wu J, Zhang Y, et al. An optimal culture condition maintains human hepatocyte phenotype after long-term culture. Hepatol Res 2006; 35: 169-177.
19. Maass N, Hojo T, Rösel F, et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001; 34: 303-307.
20. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245-248.
21. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nat Med 2000; 6: 196-199.
22. Zelvyte I, Stevens T, Westin U, et al. α1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro. Cancer Cell Int 2004; 4: 7.
23. Chua R, Setzer S, Govindarajan B, et al. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma. J Am Acad Dermatol 2009; 60: 758-766.
24. Zelvyte I, Wallmark A, Piitulainen E, et al. Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res 2004; 24: 241-247.
25. Sun Z, Yang P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol 2004; 5: 182-190.
26. Shamamian P, Pocock BJ, Schwartz JD, et al. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion. Surgery 2000; 127: 42-47.
27. Shamamian P, Schwartz JD, Pocock BJ, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 2001; 89: 197-206.
28. Stoff-Khalili MA, Rivera AA, Mathis JM, et al. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat 2007; 105: 157-167.